<b> Artisan Pharma’s Program in DIC/Sepsis </b> [Added item on Japanese approval.] <a href='read_msg.asp?message_id=27043027'>#msg-27043027</a> ART-123 approved in Japan <a href=http://208.78.96.220/documents/ART-123.pdf>Paper on ART-123 Japanese study</a> <a href='read_msg.asp?message_id=22288440'>#msg-22288440</a> Musings on the Japanese study <a href='read_msg.asp?message_id=22260580'>#msg-22260580</a> How big a threat is ART-123? <a href='read_msg.asp?message_id=22257491'>#msg-22257491</a> Phase-2b trial begins in US <a href='read_msg.asp?message_id=21829339'>#msg-21829339</a> clinicaltrials.gov listing of above trial <a href='read_msg.asp?message_id=22972952'>#msg-22972952</a> Production collaboration with A-Bio